SUBSCRIBE
SUBSCRIBE
News   FDA

S.Korea Approves Zeltia Group Cancer Drug Yondelis

May 8, 2008 | 
1 min read

MADRID, May 8 (Reuters) - Spain’s Zeltia (ZEL.MC: Quote, Profile, Research) said on Thursday its cancer drug Yondelis has been approved for sale in South Korea, pushing shares higher.

FDA Approvals Asia
MORE ON THIS TOPIC
Novo Nordisk advertising flags and logo on facade
Regulatory
Novo Nordisk Snags Kidney Disease Expansion for Ozempic in Europe
December 12, 2024
 · 
1 min read
 · 
Kate Goodwin
Mental health, illness ,brain development ,medical treatment concept, messy lines of thinks in human head , vector illustration
Neurodegenerative disease
UniQure Clears Path to Accelerated Approval for Huntington’s Gene Therapy
December 10, 2024
 · 
2 min read
 · 
Tristan Manalac
A scientist with pill bottles in front of FDA headquarters
Regulatory
FDA Action Alert: Ionis, Lexicon, Bristol Myers Squibb and More
December 9, 2024
 · 
7 min read
 · 
Tristan Manalac
Contemporary collage with a running clock and an arrow. Planning and time management concept.
Regulatory
FDA Outlines Accelerated Review Guidelines in Waning Days of Biden Administration
December 6, 2024
 · 
3 min read
 · 
Annalee Armstrong